Company news
Zhejiang Shengda Bio-pharm Co., Ltd. Class A (SSE:603079) news
Zhejiang Shengda Bio-pharm Co., Ltd. Class A news releases on 6ix. Latest, Sep 24, 2026: "Zhejiang Shengda Bio-Pharm Co., Ltd."Announcement on Redemption upon…
Press releases & updates
"Zhejiang Shengda Bio-Pharm Co., Ltd."Announcement on Redemption upon Maturity of Cash Management Products Purchased with Idle Raised Funds
September 23, 2026
"Zhejiang Shengda Bio-Pharm Co., Ltd."Special Report on the Deposit, Management and Actual Use of Raised Funds for the First Half of 2026
August 27, 2026
"Zhejiang Shengda Bio-Pharm Co., Ltd."Announcement on Progress in Repurchasing Shares
August 3, 2026
"Zhejiang Shengda Bio-Pharm Co., Ltd."Announcement on Shareholdings of Top 10 Shareholders and Top 10 Shareholders of Unrestricted Shares Concerning Share Repurchase
July 30, 2026
"Zhejiang Shengda Bio-Pharm Co., Ltd."Announcement on Initial Repurchase of Shares through Call Auction
July 29, 2026
"Zhejiang Shengda Bio-Pharm Co., Ltd."Announcement on Resolutions of the 5th Meeting of the 5th Board of Directors
July 24, 2026
"Zhejiang Shengda Bio-Pharm Co., Ltd."Announcement on Progress in Using Idle Raised Funds for Cash Management
July 21, 2026
"Zhejiang Shengda Bio-Pharm Co., Ltd."Announcement on Appointment of Board Secretary and Securities Affairs Representative
July 7, 2026
"Zhejiang Shengda Bio-Pharm Co., Ltd."Announcement on Redemption at Maturity of Idle Raised Funds Used for Cash Management
June 30, 2026
Announcement on Implementation of Dividend Distribution for 2025
June 23, 2026
Announcement on Result of Shareholding Reduction by Shareholders
May 26, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 18, 2026
Announcement on Remuneration Payment for Directors and Senior Management Members in 2025 and Remuneration Plan for Directors and Senior Management Members in 2026
April 26, 2026
Announcement on Resignation of Secretary of the Board of Directors
April 15, 2026
Announcement on Progress in Using Idle Raised Funds for Cash Management
April 14, 2026
Announcement on Redemption at Maturity of Idle Raised Funds Used for Cash Management
March 30, 2026
Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1% Scale
March 16, 2026
Announcement on Estimated Daily Related Party Transactions in 2026
February 10, 2026
Announcement on Shareholding Reduction Plan for Shareholders
January 26, 2026
Indicative Announcement on Proposed Provision for Asset Impairment
January 22, 2026
Announcement on Completing Industrial and Commercial Change Registration
January 12, 2026
Announcement on Changing Signatory Certified Public Accountant
December 29, 2025
Announcement on Lifting of Trading Restrictions for Restricted Shares Issued to Specific Objects
December 18, 2025
Announcement on Resolutions of the 4th Extraordinary General Meeting in 2025
December 15, 2025
Announcement on Progress in Idle Raised Funds Used for Cash Management
December 12, 2025
Announcement on Resolutions of the 21st Meeting of the 4th Board of Directors
November 27, 2025
Announcement on Completion of Non-trading Transfer under the 2024 Employee Stock Ownership Plan
October 30, 2025
Report for Q3 2025
October 29, 2025
Announcement on Convening the 2025 Q3 Performance Briefing
October 9, 2025
Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025
September 10, 2025
Announcement on Convening the 2025 Semi-annual Performance Briefing
September 4, 2025
Announcement on Resolutions of the 17th Meeting of the 4th Board of Supervisors
August 25, 2025
Announcement on Obtaining Government Subsidies
August 19, 2025
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
July 23, 2025
Announcement on Expected Increase in Semi-annual Performance for 2025
July 14, 2025
Announcement on Resolutions of the 18th Meeting of the 4th Board of Directors
July 7, 2025
Announcement on Results of Issuing Shares to Specific Objects and Changes in Share Capital
June 27, 2025
Announcement on Opening Special Account for Raised Funds and Signing Agreement on Supervision over Deposit in Special Account for Raised Funds
June 16, 2025
Announcement on Resolutions of the 2024 Annual General Meeting
May 26, 2025
Announcement on Resolution of the 17th Meeting of the 4th Board of Directors
May 22, 2025
Announcement on Convening the 2024 Annual and Q1 2025 Performance Briefing
May 19, 2025
Report for Q1 2025
April 27, 2025
Announcement on the Resolution of the 1st Extraordinary General Meeting in 2025
April 23, 2025